Tang Capital
View Older Stories View More Recent Stories
-
Form 4 Rain Oncology Inc. For: Oct 11 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G BIONOMICS LIMITED/FI Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Transcode Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
-
Form SC 13G/A ASLAN Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G AVROBIO, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Rain Oncology Inc. For: May 30 Filed by: TANG CAPITAL PARTNERS LP
-
Form 3 Rain Oncology Inc. For: May 30 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Atea Pharmaceuticals' (AVIR) Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
Atea Pharmaceuticals (AVIR) Confirms $5.75/sh + CVR Acquisition Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
Form SC 13D Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 TCR2 THERAPEUTICS INC. For: May 11 Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
-
Form 4 TCR2 THERAPEUTICS INC. For: May 08 Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 TCR2 THERAPEUTICS INC. For: May 03 Filed by: TANG CAPITAL PARTNERS LP
-
Form 3 TCR2 THERAPEUTICS INC. For: May 03 Filed by: TANG CAPITAL PARTNERS LP
-
Form 4 Jounce Therapeutics, For: May 03 Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G MEI Pharma, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Genfit S.A. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Bolt Biotherapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G InflaRx N.V. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Jounce Therapeutics (JNCE) to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
-
Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Bellerophon Therapeutics Filed by: TANG CAPITAL PARTNERS LP
-
Jounce Therapeutics (JNCE) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
-
Form SC 13D Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Adicet Bio, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Elevation Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G Evolus, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A REVIVA PHARMACEUTICALS Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A BioAtla, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Tarsus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Pyxis Oncology, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A ASLAN Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Corvus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A CytomX Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A KalVista Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A Altimmune, Inc. Filed by: TANG CAPITAL PARTNERS LP
-
Form 13F-HR TANG CAPITAL MANAGEMENT For: Dec 31
-
Form SC 13G/A Tonix Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
-
Form SC 13G/A ALBIREO PHARMA, INC. Filed by: TANG CAPITAL PARTNERS LP